Skip to main content
TipRanks
Go Ultimate75% OFF

Robert W Duggan Insider Profile

4 Followers

Robert W Duggan, former Director, Ten Percent Owner at Summit Therapeutics, holds 211.12M shares in Summit Therapeutics (Ticker: GB:SUMM). Most recently, Robert W Duggan Sold 33,321,870 shares of Summit Therapeutics on Jan 15, 2020 for an estimated value of 7.36M .

Robert W Duggan's Trading History

SUMM
Summit Therapeutics
Jan 15, 2020―Informative Sell7.36M£79.17M
GB:SUMM
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jan 15, 2020Informative Sell£7.36M33,321,870£22.00――
Dec 06, 2019Informative Buy£36.72M166,157,050£22.00+5.00%―
Dec 17, 2018Informative Buy$25.00M78,125,000$0.32+8.70%―

You May Also Like

Robert W Duggan insider profile FAQ

What is the percentage of profitable transactions made by Robert W Duggan?
The percentage of profitable transactions made by Robert W Duggan is 100%.
What is the average return per transaction made by Robert W Duggan?
The average return per transaction made by Robert W Duggan is 6.80%.
What stocks does Robert W Duggan hold?
Robert W Duggan holds: GB:SUMM stocks.
What was Robert W Duggan’s latest transaction?
Robert W Duggan’s latest transaction was an Informative Sell of 7.36M .
What was Robert W Duggan's most profitable transaction?
Robert W Duggan’s most profitable transaction was an Informative Buy of GB:SUMM stock on December 17, 2018. The return on the trade was 8.70%.
What is Robert W Duggan's role in Summit Therapeutics?
Robert W Duggan's role in Summit Therapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.